Summary: H.Res. 1200 (119th Congress) — Endometriosis Awareness Month (March 2026)

Purpose and Intent

• This resolution designates March 2026 as Endometriosis Awareness Month and expresses the House’s support for awareness, education, and research related to endometriosis.
• It emphasizes early detection, improved education for health care providers, and culturally competent care, with a commitment to ongoing support for research and treatment options aimed at better management, fertility outcomes, and ultimately a cure.

Key Provisions and Provisions Text

• The House resolves that it strongly supports the goals and ideals of Endometriosis Awareness Month.
• It recognizes:
  • The need for early detection and treatment of endometriosis.
  • The importance of increased education for health care providers.
  • The need for more culturally competent care.
• It reiterates the commitment to funding and supporting endometriosis research for more effective treatments, improved fertility outcomes, and the pursuit of a cure.
• It encourages the American public to observe March 2026 with awareness and educational activities targeted to inform and engage communities.

Who/What Is Affected

• Primary Audience: Members of Congress, federal agencies, health care professionals, researchers, and the general public.
• While the resolution does not impose new mandates or funding levels by itself, it signals federal attention and advocacy for:
  • Increased educational outreach about endometriosis.
  • Enhanced research funding and development of treatment guidelines.
  • More culturally competent care delivery.

Procedural and Timeline Aspects

• Introduction and Referal:
  • Introduced in the House on April 20, 2026.
  • Referred to the House Committee on Energy and Commerce.
• If enacted, the resolution would officially recognize March 2026 as Endometriosis Awareness Month and guide a period of heightened awareness activities.
• As a concurrent or simple resolution, it would not by itself create funding or statutory requirements but would express congressional support and awareness objectives.

Contextual Notes

• Endometriosis is described as a disease where tissue similar to the uterine lining grows outside the uterus.
• The bill highlights:
  • Prevalence: about 1 in 10 women of reproductive age.
  • Diagnostic challenges and delays (often requiring laparoscopy for confirmation; delays ranging from 3 to 11 years).
  • Economic and personal burden (average direct health care cost per patient over $13,000 annually; productivity losses; missed workdays and reduced work capacity).
  • Common symptoms and impacts on quality of life, relationships, and daily functioning.
• The resolution aligns with broader public health goals to improve awareness, early diagnosis, treatment options, and research for better outcomes and potential cures.

If you’d like, I can add a brief glossary of terms (e.g., laparoscopy, GnRH antagonists) or compare this resolution to similar Endometriosis Awareness Month resolutions in other sessions.